Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 22nd May 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.



Stimuli Responsive PEGylated Bismuth Selenide Hollow Nanocapsules for Fluorescence/CT imaging and Light-Driven Multimodal Tumor Therapy

Abstract

Stimuli-responsive therapeutic nanosystems exhibit enhanced selectivity and higher biosafety for cancer theranostics via recognizing exogenous or endogenous tumor- associated factors. Herein, we developed a multifunctional nanocomplex (Bi2Se3@PEG/DOX/Ce6 nanocapsules, or BPDC NCs in brief) that was constructed by loading chlorin e6 (Ce6) and doxorubicin (DOX) into PEGylated hollow bismuth sulfide nanocapsules. Upon the administration of BPDC NCs, composite laser irradiation can effectively activate the local hyperthermia generation and the yield of cytotoxic reactive oxygen species (ROS). In another aspect, on-demand drug release can be triggered in mild acidic tumor microenvironment or by thermal shock. Moreover, imaging navigation with respect to infrared thermography, computed tomography (CT) and fluorescence imaging and may potentially monitor the biodistribution of BPDC NCs, thanks to the local hyperthermia generation, fluorescence emission of Ce6 and high Z-element of bismuth. Finally, we demonstrated the tumor site-specific photothermal therapy (PTT), photodynamic therapy (PDT) and chemotherapeutic effects for high efficacious tumor suppression with minimized systemic toxicity. Taken together, these findings indeed provide insights of broadening the application of Bi2Se3 nanocapsules for cancer management and precision medicine.

Back to tab navigation

Supplementary files

Publication details

The article was received on 05 Mar 2019, accepted on 02 May 2019 and first published on 06 May 2019


Article type: Paper
DOI: 10.1039/C9BM00351G
Biomater. Sci., 2019, Accepted Manuscript

  •   Request permissions

    Stimuli Responsive PEGylated Bismuth Selenide Hollow Nanocapsules for Fluorescence/CT imaging and Light-Driven Multimodal Tumor Therapy

    L. Sun, Q. Li, L. Zhang, H. Chai, L. Yu, Z. Xu, Y. Kang and P. Xue, Biomater. Sci., 2019, Accepted Manuscript , DOI: 10.1039/C9BM00351G

Search articles by author

Spotlight

Advertisements